Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling

Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation

(2014) Jisook Lee et al.   NEURO-ONCOLOGY

STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment

(2014) T. Ohkuri et al.   Cancer Immunology Research

The Controversial Role of Microglia in Malignant Gliomas

(2013) Jun Wei et al.   Clinical & Developmental Immunology

Tumor-associated macrophages: functional diversity, clinical significance, and open questions

(2013) Subhra K. Biswas et al.   Seminars in Immunopathology

ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo

(2013) TING XU et al.   Oncology Letters

Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4

(2012) Xitong Dang et al.   CELL AND TISSUE RESEARCH

Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages

(2012) Andrew Baird et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The molecular profile of microglia under the influence of glioma

(2012) W. Li et al.   NEURO-ONCOLOGY

Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells

(2011) Mercedes B. Fuertes et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

(2011) Mark S. Diamond et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia

(2011) Wenwen Sheng et al.   Journal of Neuroinflammation

Processing of Proaugurin Is Required to Suppress Proliferation of Tumor Cell Lines

(2011) Akihiko Ozawa et al.   MOLECULAR ENDOCRINOLOGY

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

(2011) Mina J Bissell et al.   NATURE MEDICINE

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

(2011) Renaud Sabatier et al.   PLoS One

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats

(2010) JA Tadross et al.   BRITISH JOURNAL OF PHARMACOLOGY

Role of Type 1 IFNs in Antiglioma Immunosurveillance--Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

(2010) M. Fujita et al.   CLINICAL CANCER RESEARCH

Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion

(2010) Wei Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

(2009) Silke Götze et al.   BMC CANCER

Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer

(2009) Donkena Krishna Vanaja et al.   CANCER INVESTIGATION

Sox11 Prevents Tumorigenesis of Glioma-Initiating Cells by Inducing Neuronal Differentiation

(2009) T. Hide et al.   CANCER RESEARCH

Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growthin vitroandin vivo

(2009) Lin-Wei Li et al.   INTERNATIONAL JOURNAL OF CANCER

Glioblastoma Formation from Cell Population Depleted of Prominin1-Expressing Cells

(2009) Kenji Nishide et al.   PLoS One